A carregar...
Somatic mutations of the epidermal growth factor receptor and non‐small‐cell lung cancer
Frequent overexpression of epidermal growth factor receptor (EGFR) in non‐small‐cell lung cancer (NSCLC) makes EGFR a new therapeutic target. Two specific EGFR tyrosine kinase inhibitors, gefitinib (ZD1839, Iressa) and erlotinib (OSI‐774, Tarceva), have been developed and approved by the US Food and...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2598028/ https://ncbi.nlm.nih.gov/pubmed/17158592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2006.046102 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|